Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs used to treat inflammation may cause hair loss.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Hair loss is common in IBD patients, and some medications may lower the risk.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

A woman's hair loss was caused by her husband's testosterone gel and a diabetic man's nail disease led to bone infection, both treated successfully.

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

TNF-alpha inhibitors can cause various immune-related skin issues.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Blocking interferon-gamma might help treat various autoimmune diseases.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.